WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Breast Cancer Endpoints - Master Primary m5, Tumor assessment provides_evidence_for Disease recurrence, Adjuvant setting endpoints has_component Disease free survival (DFS), Date of recurrence has_component Tumor assessment, Concepts (e.g. CRF:pCR:Surgical margins are denoted by solid round-edged rectangle, Receptor status has_component PR, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_pertinent_information Cancer stage, No - Non-invasive has_follow_up _assessment In situ carcinoma, Yes has_component Surgical margins, Cancer stage has_component T, Curative intent has_option Neoadjuvant setting endpoints, Cancer stage has_component N, Therapeutic Efficacy Point has Observation or Assessment, Disease free survival (DFS) has_pertinent_information No disease present, Demographics/Medical history has_components Demographics/Medical history, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_pertinent_information Tumor Biopsy, Neoadjuvant setting endpoints has_component Pathologic complete response (pCR), Date of progression has_component Tumor assessment, Disease free survival (DFS) ends_concurrent_with Date of recurrence, Therapeutic Efficacy Point has Therapeutic/Surgical intervention, Progression free survival (PFS) ends_concurrent_with Date of death of any cause